About Tecnimede
Tecnimede Group, established in the 1980s, is a pioneering Portuguese pharmaceutical company committed to advancing healthcare through cutting-edge Pharmaceutical Technology and high-quality treatment solutions.
Since its inception, Tecnimede has grown into Portugal’s largest pharmaceutical company, with a presence in over 100 international markets and a strong reputation for research and innovation.
Our mission is to deliver value-added therapies that address complex healthcare needs, particularly in the management of chronic diseases such as hypertension, diabetes, chronic pain, osteoporosis and respiratory conditions. Tecnimede places patients at the centre of its activity, striving to improve quality of life through scientifically driven, effective and accessible treatments.
Our investment in research and development supports the exploration of emerging technologies, including cell therapy, advanced drug delivery systems and precision medicine, helping us develop solutions that respond to the evolving needs of patients worldwide.
The Tecnimede Open Innovation Competition extends this commitment to Pharmaceutical Technology by fostering collaboration and encouraging innovative thinking. Through the Competition, Tecnimede aims to identify transformative solutions and connect with innovators working to push the boundaries of healthcare.
